Veeva Systems (NYSE: VEEV) today announced the biopharma keynote speakers for Veeva R&D and Quality Summit, Europe, June 4-5 in Madrid, Spain. Biopharma professionals will convene to learn how the industry is advancing across clinical, regulatory, safety, and quality. The opening keynote will also highlight Veeva AI, a major initiative to add AI to the Veeva Vault Platform and Veeva applications to help automate critical functions and improve productivity.
As one of the largest gatherings of life sciences leaders in Europe, Veeva R&D and Quality Summit will bring together over 1,400 industry professionals in more than 100 sessions. Novo Nordisk and Recipharm will join Rik Van Mol, senior vice president of R&D and Quality, and Avril England, general manager of Veeva Vault, for the opening keynote to explore the development and manufacturing of new medicines and therapies.
The event’s zone keynotes include:
- Bayer, discussing how it is streamlining its clinical infrastructure with a customer-centric approach to working with sites
- Lonza, a leading CDMO, sharing how the evolving industry ecosystem is reshaping quality management across partners
- MSD, discussing how it is innovating its pharmacovigilance operations and improving efficiency by building a trusted data foundation
- Novo Nordisk, sharing how it accelerates clinical trials and launches by uniting business and IT on Veeva Development Cloud to enhance collaboration, automation, and data consistency
- Teva, highlighting how innovation, agility, and a data-driven mindset are helping it navigate regulatory change and drive efficiency
“Fresh thinking and a strong community are essential to transforming how we bring medicines to patients,” says Rik Van Mol, senior vice president of R&D and Quality. “At Veeva R&D and Quality Summit, leaders come together to spark new ideas, share breakthroughs, and shape the future of the industry together.”
